A Selective Neutraligand for CXCL12/SDF-1α With Beneficial Regulatory Functions in MRL/Lpr Lupus Prone Mice.

Front Pharmacol · 2021 · PMC8566942 · PMID 34744730

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In order to avoid any over-interpretation of the results, highly significant differences only have been highlighted, namely changes greater than 1.25-fold in all 9 comparisons in the 3 × 3 matrix comparison method.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.